Virtu Financial’s ADMA Biologics ADMA Stock Holding History

Virtu Financial’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$137K	Buy	+16,423	New	+$150K	﹤0.01%	1041
2025 Q4	–	Sell	-19,200	Closed	-$281K	–	1592
2025 Q3	$281K	Buy	19,200 +1,990	+12%	+$34.1K	0.02%	766
2025 Q2	$313K	Buy	+17,210	New	+$351K	0.02%	736
2025 Q1	–	Sell	-18,992	Closed	-$326K	–	1289
2024 Q4	$326K	Buy	+18,992	New	+$357K	0.02%	663
2023 Q3	–	Sell	-24,684	Closed	-$91K	–	1225
2023 Q2	$91K	Buy	+24,684	New	+$91.5K	0.01%	1058
2022 Q4	–	Sell	-36,123	Closed	-$88K	–	1528
2022 Q3	$88K	Buy	36,123 +18,935	+110%	+$45.4K	0.01%	1111
2022 Q2	$34K	Buy	+17,188	New	+$33.8K	﹤0.01%	1221
2022 Q1	–	Sell	-88,315	Closed	-$125K	–	1445
2021 Q4	$125K	Buy	+88,315	New	+$116K	0.01%	1030
2020 Q4	–	Sell	-93,705	Closed	-$224K	–	1399
2020 Q3	$224K	Buy	+93,705	New	+$257K	0.04%	556
2018 Q1	–	Sell	-23,188	Closed	-$74K	–	1891
2017 Q4	$74K	Buy	+23,188	New	+$64.9K	﹤0.01%	1992

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Virtu Financial's ADMA Position: Q2 2026 in Review

Virtu Financial opened a new position in ADMA Biologics (ADMA) in Q2 2026: 16,423 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #1041 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ADMA as recently as Q3 2025.

Virtu Financial first reported a position in ADMA in Q4 2017 and has held it in 10 quarters since. The position peaked at $326K in Q4 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Virtu Financial held 16,423 shares of ADMA Biologics worth $137K as of Q2 2026.
ADMA Biologics was a new Virtu Financial position in Q2 2026.
ADMA Biologics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1041 holding.
Virtu Financial first reported a position in ADMA Biologics in Q4 2017 and has held it in 10 quarters since.
Virtu Financial's ADMA Biologics position peaked at $326K in Q4 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.